Cytena
ExitedCytena develops single-cell printing technology for cell research and professional diagnostics.
Cytena has raised €3.0M across 1 funding round from 1 investor, most recently a Series A round in Jan 2019. Based in Freiburg, Germany; founded 2014; active in Healthtech. Acquired by CELLINK in 2019. Data as of 28 Oct 2026.
Total raised
€3.0M
€3,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2019-01
latest 2019-01
Funding by year
EUR raised per yearCytena — funding by year — interactive chart.
Data table
| Cytena — funding by year | |
|---|---|
| 2018 | €3.0M |
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-01-01 | Series A | €3.0M | High-Tech Gründerfonds (HTGF) | View deal → |
Exit
Investors
1Related news
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData